查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1471071

血浆分馏市场：按产品、应用和最终用户划分 - 2024-2030 年全球预测

Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

血浆分馏市场规模预计2023年为355.2亿美元，2024年达389.5亿美元，预计2030年将达到712.7亿美元，复合年增长率为10.45%。

血浆分馏是指收集、分离和精製人类血浆中存在的各种必需成分，主要包括白蛋白、免疫球蛋白、凝血因子和其他蛋白质。这些成分在医学上有许多用途，包括血友病治疗、免疫疾病治疗、创伤治疗支持、神经治疗和其他罕见疾病。由于原始血浆是多种救生治疗的关键组成部分，对原始血浆的需求正在稳步增长。这种激增是由于人口老化和免疫疾病盛行率上升所致，这些疾病更容易患上需要血液治疗的慢性疾病。此外，患者对血液相关疾病的认识不断提高也大大促进了该市场的扩张。然而，政府对血浆分馏和替代重组疗法的严格监管可能会阻碍市场需求。生产技术的新进步将进一步增加该领域参与者的商机。此外，预计各相关人员之间的策略联盟将推动产业内的创新研究工作，提供新颖的解决方案并在预测期内创造利润丰厚的市场机会。

主要市场统计
基准年[2023] 355.2亿美元
预测年份 [2024] 389.5亿美元
预测年份 [2030] 712.7亿美元
复合年增长率（%） 10.45%

在产品免疫球蛋白精製中增加血浆分馏的使用

白蛋白是一种主要的血浆蛋白，对于调节血液容量和运输多种物质（包括荷尔蒙、药物和营养物质）非常重要。免疫球蛋白製剂主要用于治疗低血容、低白蛋白血症和严重烧伤。凝血因子浓缩物对于治疗A型血友病等出血性疾病至关重要，并且可以促进血管性血友病的癒合。免疫球蛋白是透过中和细菌和病毒等病原体在人体免疫反应中发挥重要作用的抗体，通常用于原发性免疫力缺乏疾病、发炎疾病、自体免疫疾病和某些类型的癌症的治疗。蛋白酶抑制剂对于治疗遗传性血管性水肿 (HAE) 至关重要。遗传性血管性水肿是一种週期性遗传性疾病，其特征是身体不同部位反覆发作严重肿胀。这些抑制剂可阻断蛋白酶的作用，从而在遗传性血管性水肿 (HAE) 发作期间引起发炎和血管渗透性。

应用 扩大在血液疾病治疗的应用

在重症加护中，血浆分馏产品对于治疗败血症、烧伤和创伤等危及生命的疾病至关重要。血浆分馏在血液肿瘤学中具有重要应用，可支持血液相关癌症的治疗和化疗。血液学涉及血友病和冯维勒布兰德病 (VWD) 等血液疾病的预防、诊断和治疗。含有 IVIG 的血浆分馏产品越来越多地用于治疗神经系统疾病，如Guillain-Barré二氏症候群、慢性脱髓鞘多发性神经炎(CIDP) 和多发性硬化症。在呼吸系统医学中，血浆分馏可用于治疗 α-1 抗胰蛋白酶缺乏症 (AATD) 和急性呼吸窘迫症候群(ARDS) 等呼吸系统疾病。血浆分馏用于风湿病学，主要透过使用 IVIG 来治疗自体免疫和发炎疾病。

最终用户：血浆分馏广泛用于临床研究实验室，以确保血浆衍生产品的安全性和有效性。

学术和研究机构从事基础研究，以提高我们对血浆蛋白及其治疗潜力的了解。此细分市场的主要需求包括用于蛋白质表征研究的高纯度血浆分馏、用于发现的先进分馏技术以及获得可靠的原料来源。临床研究实验室对于测试和检验製程和产品至关重要。我们进行测试以确保血浆衍生产品的安全性和有效性，评估患者影响并收集资料以支持监管核准。这些实验室参与产品开发的临床前和临床阶段。

区域洞察

由于其完善的医疗基础设施、免疫不全症的高盛行率以及不断增长的老年人口，美洲在血浆分馏市场中占有重要地位。在欧洲，欧盟国家拥有强而有力的法规结构来管理血浆分馏产业。欧洲药品管理局 (EMA) 负责监管血液产品的製造方法并监督品质标准，是该地区市场需求的主要推动者。由于收入的增加和医疗保健服务的扩大，中东和非洲地区提供了利润丰厚的机会。在亚太地区，快速的都市化和经济发展正在推动医疗基础设施投资，市场格局正在向新兴市场演变。此外，亚太地区各国政府也越来越关注血液安全法规，为市场进入者创造了机会。

FPNV定位矩阵

FPNV定位矩阵对于评估血浆分馏市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对血浆分馏市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.血浆分馏市场的市场规模与预测是多少？

2.血浆分馏市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.血浆分馏市场的技术趋势和法规结构是什么？

4.血浆分馏市场主要厂商的市场占有率为何？

5.进入血浆分馏市场适合的形式和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 改善血浆治疗的可及性并在各个治疗领域大量使用免疫球蛋白
      • 政府努力增加血浆采集
      • 随着世界各地老年人数量的增加，采血设施的数量也增加。
    • 抑制因素
      • 存在对目前病毒灭活治疗具有抗药性的新病原体
    • 机会
      • 製程开发技术的不断进步以改进配方
      • 新临床试验的爆炸性使用以及血浆治疗研发活动的扩展
    • 任务
      • 关于血浆分馏和替代重组疗法的存在的严格政府法规
  • 市场区隔分析
    • 产品：增加血浆分馏在免疫球蛋白精製的使用
    • 用途：越来越多用于治疗血液疾病
    • 最终用户：血浆分馏广泛用于临床研究实验室，以确保血浆衍生产品的安全性和有效性。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章血浆分馏市场：副产品

  • 白蛋白
  • 浓缩凝血因子
  • 免疫球蛋白
  • 蛋白酶抑制剂

第七章血浆分馏市场：依应用分类

  • 加护治疗
  • 血液肿瘤学
  • 血液学
  • 神经病学
  • 呼吸系统医疗设备
  • 风湿病学

第八章血浆分馏市场：依最终用户分类

  • 学术研究所
  • 临床研究实验室

第九章美洲血浆分馏市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太血浆分馏市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲血浆分馏市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Grifols 埃及运送第一批由埃及捐赠血浆製成的血浆药物
    • CSL 耗资 4.7 亿美元的血浆分馏设施在德国马尔堡开业
    • 武田投资 1000 亿日圆在日本新血浆分馏产品生产设施
    • Kedrion 在沙乌地阿拉伯的血浆分馏研讨会上发表演讲
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4312A385A58A

[197 Pages Report] The Plasma Fractionation Market size was estimated at USD 35.52 billion in 2023 and expected to reach USD 38.95 billion in 2024, at a CAGR 10.45% to reach USD 71.27 billion by 2030.

Plasma fractionation refers to collecting, separating, and purifying various essential components present in human plasma, primarily including albumin, immunoglobulins, coagulation factors, and other proteins. These components have many applications in medical treatments, such as hemophilia therapy, immunity disorders treatment, wound healing support, neurology therapy, and other rare diseases. The demand for source plasma has been steadily increasing due to its role as a vital ingredient in several life-saving therapies. This surge can be attributed to an aging population prone to chronic illnesses requiring blood-based therapies and the rising prevalence of immune disorders. In addition, rising awareness about blood-related diseases among patients contributes significantly to this market's expansion. However, stringent government regulations on plasma fractionation and the presence of alternative recombinant therapies may hamper the market demand. New advancements in production technology further boost opportunities for the players involved in this field. Moreover, strategic collaborations among various stakeholders drive innovative research work within the industry that provides novel solutions and is expected to create a lucrative market opportunity in the forecasted period.

KEY MARKET STATISTICS
Base Year [2023] USD 35.52 billion
Estimated Year [2024] USD 38.95 billion
Forecast Year [2030] USD 71.27 billion
CAGR (%) 10.45%

Product: Rising use of plasma fractionation for immunoglobulins purification

Albumin is a major plasma protein critical in regulating blood volume and transporting various substances, including hormones, drugs, and nutrients. It primarily treats hypovolemia (low blood volume), hypoalbuminemia (low albumin levels), and severe burns. Coagulation factor concentrates are essential for treating bleeding disorders such as hemophilia A & B and von Willebrand disease and replace missing or deficient clotting factors, preventing excessive bleeding and promoting proper wound healing. Immunoglobulins are antibodies that play a crucial role in the body's immune response by neutralizing pathogens such as bacteria and viruses and are used to treat primary immunodeficiency diseases, inflammatory and autoimmune disorders, and certain types of cancer. Protease inhibitors are essential for managing hereditary angioedema (HAE), a periodic genetic condition characterized by recurrent episodes of severe swelling in various body parts. These inhibitors block the action of proteases responsible for inflammation and vascular permeability during hereditary angioedema (HAE) attacks.

Application: Proliferating use to treat hematological disorders

In the critical care setting, plasma fractionation products are vital for treating life-threatening conditions such as sepsis, burns, and trauma. Plasma fractionation has significant applications in hemato-oncology for managing blood-related cancers and supporting chemotherapy treatments. Hematology involves the prevention, diagnosis, and treatment of blood diseases such as hemophilia or von Willebrand disease (VWD). Plasma fractionation products including IVIG are increasingly used in treating neurological conditions, including Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple sclerosis. In pulmonology, plasma fractionation helps in managing respiratory diseases such as alpha-1 antitrypsin deficiency (AATD) and acute respiratory distress syndrome (ARDS). Plasma fractionation is utilized in rheumatology primarily through the use of IVIG to manage autoimmune and inflammatory disorders.

End-User: Extensive use of plasma fractionation in clinical research laboratories to ensure the safety and efficacy of plasma-derived products

Academic & research institutes are engaged in basic research to advance the understanding of plasma proteins and their therapeutic potential. The key needs for this segment include high-purity plasma fractions for protein characterization studies, advanced fractionation techniques that can lead to discoveries, and access to reliable sources of raw material. Clinical research laboratories are essential for testing and validating plasma fractionation processes and products. They conduct trials to ensure the safety and efficacy of plasma-derived products, assess their impact on patients, and gather data to support regulatory approval. These laboratories are involved in both pre-clinical and clinical stages of product development.

Regional Insights

The Americas has a significant market presence in the plasma fractionation market due to a well-established healthcare infrastructure, high prevalence of immunodeficiency diseases, and an increasing geriatric population. In Europe, EU countries have a strong regulatory framework governing the plasma fractionation industry. The European Medicines Agency (EMA) regulates manufacturing practices and oversees quality standards for blood-derived products, significantly driving the region's market demand. The MEA region presents lucrative opportunities due to rising incomes and expanding access to healthcare services. The Asia-Pacific observed a developing landscape in the plasma fractionation market owing to rapid urbanization and economic development that is driving investments in healthcare infrastructure. Additionally, there is an increasing focus on blood safety regulations by governments in the APAC region, presenting opportunities for market players.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Plasma Fractionation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Plasma Fractionation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Plasma Fractionation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ADMA Biologics, Inc., Bharat Serums and Vaccines Limited, Bio Products Laboratory Ltd., Biotest AG by Grifols, S.A., China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Fusion Health Care Pvt. Ltd., GC Biopharma corp., Grifols, S.A., HEINKEL Process Technology GmbH, Hemarus Therapeutics Ltd, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion S.p.A., LFB SA, Merck KGaA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions B.V., Sanquin, Shanghai Raas Blood Products Co. Ltd, SK Plasma Co.,Ltd., STERIS plc, and Takeda Pharmaceutical Company Ltd.

Market Segmentation & Coverage

This research report categorizes the Plasma Fractionation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Albumin
    • Coagulation Factor Concentrates
      • Factor IX
      • Factor VIII
      • Factor XIII
      • Fibrinogen Concentrates
      • Prothrombin Complex Concentrate
      • Von Willebrand Factor
    • Immunoglobulin
      • Intravenous Immunoglobulin
      • Subcutaneous Immunoglobulin
    • Protease Inhibitors
  • Application
    • Critical Care
    • Hemato-Oncology
    • Hematology
    • Neurology
    • Pulmonology
    • Rheumatology
  • End-User
    • Academic & Research Institutes
    • Clinical Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Plasma Fractionation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Plasma Fractionation Market?

3. What are the technology trends and regulatory frameworks in the Plasma Fractionation Market?

4. What is the market share of the leading vendors in the Plasma Fractionation Market?

5. Which modes and strategic moves are suitable for entering the Plasma Fractionation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Improving access to plasma-based therapies and high use of immunoglobulins in various therapeutic areas
      • 5.1.1.2. Government initiatives to increase plasma collection
      • 5.1.1.3. Growing prevalence of elderly people around the globe and the increasing number of blood collection facilities
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of new pathogenic agents that resist the present viral inactivation treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous advancements in process development technology for improved formulations
      • 5.1.3.2. Exponential utilization in new clinical trials and growing R&D activities in plasma treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations on plasma fractionation and the presence of alternative recombinant therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising use of plasma fractionation for immunoglobulins purification
    • 5.2.2. Application: Proliferating use to treat hematological disorders
    • 5.2.3. End-User: Extensive use of plasma fractionation in clinical research laboratories to ensure the safety and efficacy of plasma-derived products
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Plasma Fractionation Market, by Product

  • 6.1. Introduction
  • 6.2. Albumin
  • 6.3. Coagulation Factor Concentrates
  • 6.4. Immunoglobulin
  • 6.5. Protease Inhibitors

7. Plasma Fractionation Market, by Application

  • 7.1. Introduction
  • 7.2. Critical Care
  • 7.3. Hemato-Oncology
  • 7.4. Hematology
  • 7.5. Neurology
  • 7.6. Pulmonology
  • 7.7. Rheumatology

8. Plasma Fractionation Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Clinical Research Laboratories

9. Americas Plasma Fractionation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Plasma Fractionation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Plasma Fractionation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Grifols Egypt delivers first plasma medicines made from Egyptian plasma donations
    • 12.3.2. CSL's USD470 Million Plasma Fractionation Facility Opens in Marburg, Germany
    • 12.3.3. Takeda to Invest 100 Billion JPY in a New Manufacturing Facility for Plasma-Derived Therapies in Japan
    • 12.3.4. Kedrion presented at plasma fractionation workshop in Saudi Arabia
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PLASMA FRACTIONATION MARKET RESEARCH PROCESS
  • FIGURE 2. PLASMA FRACTIONATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PLASMA FRACTIONATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PLASMA FRACTIONATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR IX, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR VIII, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR XIII, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR XIII, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FIBRINOGEN CONCENTRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FIBRINOGEN CONCENTRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 324. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
  • TABLE 329. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
  • TABLE 330. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
  • TABLE 331. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2